The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The CDC concludes its emergency response for H5N1 bird flu due to decreased animal infections and no new human cases since ...

The U.S. Centers for Disease Control and Prevention has merged H5N1 bird flu updates with routine updates for seasonal ...

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

REUTERS — The U.S. Centers for Disease Control and Prevention has ended its emergency response for H5N1 avian flu, owing to a decline in animal infections and no reports of human cases since February.

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines. The shot’s efficacy was 27 percent ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans. When asked about the uncertain regulatory environment in the U.S., ...

The Trump administration recently canceled $766 million in contracts with Moderna to develop and produce an mRNA vaccine against pandemic influenza viruses, including H5N1 avian flu.

Short sellers started to panic in recent days. Moderna (MRNA), which has a short interest of 16.44%, might benefit from two ...